Brief: ODI Pharma Reports Revised Qtrly Result Per Share Amounted To SEK -0.09 (-0.05)
25/02/2022 20:42
Feb 25 (Reuters) - Odi Pharma AB (publ) ODI.TE :
* DISCLOSES A REVISED HALF-YEAR REPORT FOR PERIOD JULY -
DECEMBER
2021
* QTRLY RESULT PER SHARE AMOUNTED TO SEK -0.09 (-0.05)
* HALF YEAR RESULT PER SHARE AMOUNTED TO SEK -0.17 (-0.13)
* GROUP'S LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK
-1,401,502
(-771,779) IN Q2
* HALF YEAR LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK
-2,576,890 (-2,039,886)
Source text for Eikon: ID:nWkr1hGwsY
Further company coverage: ODI.TE
((Reuters.briefs@thomsonreuters.com;))
Recent news on Odi Pharma AB (publ)
See all newsBrief: Odi Pharma Proposes Directed Share Issue Of Approximately Sek 2.0 Million
Brief: ODI Pharma Reports Revised Qtrly Result Per Share Amounted To SEK -0.09 (-0.05)
Brief: ODI Pharma Says Group's Net Sales For Q2 Amounted To Sek 458,620
Brief: ODI Pharma Says Group's Net Sales For Q3 Amounted To SEK 0 (SEK 1,567)
Brief: ODI Pharma Q2 Loss After Financial Items Narrows To SEK 0.8 Mln